Obsessive-compulsive disorder: Cerebral calcium deficiency as a possible etiologic/pathogenetic factor - A case study

Medical Hypotheses

Volumn 49, Issue 6, 1997, Pages 513-514

  Oken, R J ^a  

^a P O Box 412 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; ENALAPRIL MALEATE; NEUROTRANSMITTER; SEROTONIN UPTAKE INHIBITOR; VERAPAMIL;

AGED; CALCIUM DEFICIENCY; CASE REPORT; HUMAN; MALE; OBSESSION; PAROXYSMAL TACHYCARDIA; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0031440864     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(97)90071-2     Document Type: Article

References (7)

1. Modell S C, Mountz J M, Curtis G C, Greden J F. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 1989; 1: 27-36.
2. Baxter L R, Phelps M E, Mazziotta J C. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Arch Gen Psychiatry 1987; 44: 211-218.
3. Swoboda K J, Jenike M A. Frontal abnormalities in a patient with obsessive-compulsive disorder. Neurology 1995; 45(12): 2130-2134.
4. Lucey J V, Costa D C, Blanes T et al. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Br J Psychiatry 1995; 167: 629-634.
5. McDougle C J, Goodman W K, Leckman J F, Price L H. The psychopharmacology of obsessive-compulsive disorder: implications for treatment and pathogenesis. Psychiat Clin North Am 1993; 16: 749-766.
6. Leckman J F, Goodman W K, Anderson G M et al. Cerebral fluid biogenic amines in obsessive-compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology 1995; 12(1): 73-86.
7. Bezprozvanny I, Scheller R H, Tsien R W. Functional impact of syntaxin on gating of N-type and Q-type calcium channels. Nature 1995; 378: 623-626.